Zoetis (ZTS) - Short-Term Debt to Equity

Seamless partnerships with contract manufacturing plants guarantee Zoetis Inc. (ZTS) stable medication supplies. This short-term debt-to-equity chart on GURU.Markets reflects financial stability, with the value holding at 0.14. This confirms the status of the veterinary sector leader with a powerful patent shield, while high loyalty among its research staff solidifies the company's dominance in the global market.
Summary analytical data breakdowns for zoetis.com (ZTS)

Zoetis Inc. represents a highly reliable asset with a stable risk profile for long-term capital. This metric measures the company's dependence on obligations maturing within one year relative to equity, determining current liquidity. By analyzing the share of short-term loans in equity, an investor assesses the risk of refinancing liabilities. Low geopolitical pressure and stable demand for pharmaceuticals minimize the volatility of this indicator, confirming the business's financial autonomy.